We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > CHEMO

News List

Delay in Time to Chemo Impacts Survival in Breast Cancer drugs
July 30, 2019
Delay in initiation of chemotherapy is associated with poorer overall survival for breast cancer...
ASCO: Pembrolizumab Noninferior to Chemo in Advanced Gastric Cancer drugs
June 04, 2019
ASCO: Pembrolizumab Noninferior to Chemo in Advanced Gastric Cancer.
ASCO: Low-Dose Chemo Benefits Advanced Gastroesophageal Cancer drugs
June 04, 2019
Low-Dose Chemo Benefits Advanced Gastroesophageal Cancer.
SABCS: Delaying Chemo Lowers Survival in Triple-Neg Breast CA drugs
December 06, 2018
Delaying initiation of adjuvant chemotherapy in triple-negative breast cancer (TNBC) patients more than 30 days after surgery is associated with....
EU reviewing MSD’s Keytruda/chemo combo pharmatimes
April 25, 2018
European regulators have kicked off a review of MSD’s Keytruda/pemetrexed combination for the first-line treatment of patients with metastatic nonsquamous non-small cell lung cancer (NSCLC).